Literature DB >> 20571954

Genetic diversity of chromosomal metallo-beta-lactamase genes in clinical isolates of Elizabethkingia meningoseptica from Korea.

Jong Hwa Yum1, Eun Young Lee, Sung-Ho Hur, Seok Hoon Jeong, Hyukmin Lee, Dongeun Yong, Yunsop Chong, Eun-Woo Lee, Patrice Nordmann, Kyungwon Lee.   

Abstract

This study was performed to characterize the chromosomal metallo-beta-lactamases (MBLs) of Elizabethkingia meningoseptica isolated from Korea and to propose a clustering method of BlaB and GOB MBLs based on their amino acid similarities. Chromosomal MBL genes were amplified by PCR from 31 clinical isolates of E. meningoseptica. These PCR products were then cloned into a vector and electrotransformed into E. coli DH5 alpha. Nucleotide sequencing was performed by the dideoxy chain termination method using PCR products or cloned DNA fragments. Antimicrobial susceptibilities were determined by the agar dilution method. PCR experiments showed that all 31 E. meningoseptica isolates contained both the blaB and the bla (GOB) genes. DNA sequence analysis revealed that E. meningoseptica isolates possessed seven types of blaB gene, including five novel variants (blaB-9 to blaB-13) and 11 types of bla (GOB) gene, including 10 novel variants (bla (GOB-8) to bla (GOB-17)). The most common combination of MBL was BlaB-12 plus GOB-17 (n=19). Minimum inhibitory concentrations of imipenem and meropenem for the electrotransformants harboring novel BlaB and GOB MBLs were two- or four-fold higher than those for the recipient E. coli DH5 alpha. BlaB and GOB MBLs were grouped in three and six clusters including fifteen novel variants, respectively, based on amino acid similarities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571954     DOI: 10.1007/s12275-010-9308-5

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  15 in total

1.  Epidemic meningitis of the newborn caused by flavobacteria. II. Clinical manifestations and treatment.

Authors:  R M GEORGE; C P COCHRAN; W E WHEELER
Journal:  Am J Dis Child       Date:  1961-03

2.  Tigecycline and colistin susceptibility of Chryseobacterium meningosepticum isolated from blood in Taiwan.

Authors:  Yi-Tsung Lin; Yu-Jiun Chan; Cheng-Hsun Chiu; Mei-Lin Lin; Kwok-Woon Yu; Fu-Der Wang; Cheng-Yi Liu
Journal:  Int J Antimicrob Agents       Date:  2009-03-03       Impact factor: 5.283

3.  16S rRNA gene-based detection of tetrachloroethene-dechlorinating Desulfuromonas and Dehalococcoides species.

Authors:  F E Löffler; Q Sun; J Li; J M Tiedje
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

4.  Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate.

Authors:  L Lauretti; M L Riccio; A Mazzariol; G Cornaglia; G Amicosante; R Fontana; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

5.  Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile.

Authors:  G M Rossolini; N Franceschini; M L Riccio; P S Mercuri; M Perilli; M Galleni; J M Frere; G Amicosante
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

6.  Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method.

Authors:  A B Sørensen; M Duch; P Jørgensen; F S Pedersen
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 7.  Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review.

Authors:  K C Bloch; R Nadarajah; R Jacobs
Journal:  Medicine (Baltimore)       Date:  1997-01       Impact factor: 1.889

8.  Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov.

Authors:  Kwang Kyu Kim; Myung Kyum Kim; Ju Hyoung Lim; Hye Yoon Park; Sung-Taik Lee
Journal:  Int J Syst Evol Microbiol       Date:  2005-05       Impact factor: 2.747

9.  Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp.

Authors:  Kyungwon Lee; Gyoung Yim Ha; Bo-Moon Shin; Jin Ju Kim; Jung Oak Kang; Sook Jin Jang; Dongeun Yong; Yunsop Chong
Journal:  Diagn Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.803

10.  Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).

Authors:  Jeffrey T Kirby; Helio S Sader; Timothy R Walsh; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

View more
  12 in total

1.  Whole-genome sequence of Chryseobacterium oranimense, a colistin-resistant bacterium isolated from a cystic fibrosis patient in France.

Authors:  Poonam Sharma; Sushim Kumar Gupta; Seydina M Diene; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

2.  Relative Prevalence and Antimicrobial Susceptibility of Clinical Isolates of Elizabethkingia Species Based on 16S rRNA Gene Sequencing.

Authors:  Mi-Soon Han; Hyunsoo Kim; Yangsoon Lee; Myungsook Kim; Nam Su Ku; Jun Yong Choi; Dongeun Yong; Seok Hoon Jeong; Kyungwon Lee; Yunsop Chong
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

3.  In vitro activities of imipenem, vancomycin, and rifampicin against clinical Elizabethkingia species producing BlaB and GOB metallo-beta-lactamases.

Authors:  Tein-Yao Chang; Hsing-Yu Chen; Yu-Ching Chou; Yun-Hsiang Cheng; Jun-Ren Sun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-27       Impact factor: 3.267

Review 4.  Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.

Authors:  Anou M Somboro; John Osei Sekyere; Daniel G Amoako; Sabiha Y Essack; Linda A Bester
Journal:  Appl Environ Microbiol       Date:  2018-08-31       Impact factor: 4.792

5.  Elizabethkingia meningosepticum (Chryseobacterium meningosepticum) Infections in Children.

Authors:  Mehmet Ceyhan; Melda Celik
Journal:  Int J Pediatr       Date:  2011-10-20

6.  Elizabethkingia Meningoseptica Engodenous Endophthalmitis - a case report.

Authors:  Stephanie Ming Young; Gopal Lingam; Paul Anantharajah Tambyah
Journal:  Antimicrob Resist Infect Control       Date:  2014-11-26       Impact factor: 4.887

7.  Insights from the genome annotation of Elizabethkingia anophelis from the malaria vector Anopheles gambiae.

Authors:  Phanidhar Kukutla; Bo G Lindberg; Dong Pei; Melanie Rayl; Wanqin Yu; Matthew Steritz; Ingrid Faye; Jiannong Xu
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

8.  Risk Factors for Elizabethkingia Acquisition and Clinical Characteristics of Patients, South Korea.

Authors:  Min Hyuk Choi; Myungsook Kim; Su Jin Jeong; Jun Yong Choi; In-Yong Lee; Tai-Soon Yong; Dongeun Yong; Seok Hoon Jeong; Kyungwon Lee
Journal:  Emerg Infect Dis       Date:  2019-01       Impact factor: 6.883

9.  Draft Genome Sequences of Elizabethkingia meningoseptica.

Authors:  Stephanie A Matyi; Peter R Hoyt; Akira Hosoyama; Atsushi Yamazoe; Nobuyuki Fujita; John E Gustafson
Journal:  Genome Announc       Date:  2013-07-11

10.  Molecular Characteristics and Antimicrobial Susceptibility Profiles of Elizabethkingia Clinical Isolates in Shanghai, China.

Authors:  Leilei Wang; Xuefei Zhang; Dan Li; Fupin Hu; Minggui Wang; Qinglan Guo; Fan Yang
Journal:  Infect Drug Resist       Date:  2020-01-29       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.